Project Details
Description
Relevance:
The projects described in this Program Project are based on the study of patients with
well-defined genetic immune defects that prevent the producing of antibodies. Patients
with these immune defects are prone to serious and recurrent infections, an in some
cases, autoimmune diseases. Our studies have the goal of understanding of how
humans are efficiently immunized to produce antibodies after vaccination or infection,
and how autoimmunity is controlled.
| Status | Finished |
|---|---|
| Effective start/end date | 15/09/04 → 31/07/22 |
Funding
- National Institute of Allergy and Infectious Diseases: $1,416,775.00
- National Institute of Allergy and Infectious Diseases: $2,125,273.00
- National Institute of Allergy and Infectious Diseases: $1,924,836.00
- National Institute of Allergy and Infectious Diseases: $1,525,650.00
- National Institute of Allergy and Infectious Diseases: $1,999,734.00
- National Institute of Allergy and Infectious Diseases: $735,485.00
- National Institute of Allergy and Infectious Diseases: $1,409,196.00
- National Institute of Allergy and Infectious Diseases: $2,141,918.00
- National Institute of Allergy and Infectious Diseases: $1,925,282.00
- National Institute of Allergy and Infectious Diseases: $1,416,286.00
- National Institute of Allergy and Infectious Diseases: $2,136,538.00
- National Institute of Allergy and Infectious Diseases: $1,809,366.00
- National Institute of Allergy and Infectious Diseases: $1,924,821.00
- National Institute of Allergy and Infectious Diseases: $1,573,400.00
- National Institute of Allergy and Infectious Diseases: $2,130,985.00
- National Institute of Allergy and Infectious Diseases: $2,181,897.00
- National Institute of Allergy and Infectious Diseases: $1,420,556.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.